Application Notes

Due Bio’s LF-detect 3-Plex strips enable simultaneous detection of three distinct targets in a single reaction—reducing costs and accelerating results.

Due Bio’s LF-detect lateral flow strips provide a simple, visual readout solution for CRISPR-Cas12/13 assays that delivers clear results within 15 minutes—no instruments required.

# POCT Supply Chain Management: Lessons from the 2024-2025 Global Disruptions **Category:** Application Notes **Keywords:** POCT supply chain, IVD manufacturing, medical device logistics, reagent sourcing — ## Executive Summary The 2024-2025 global supply chain disruptions taught IVD manufacturers critical lessons about resilience, diversification, and risk management. This article analyzes what happened and how to protect … Read more

# TRF Technology in POCT: Why Europium Chelates Still Dominate in 2026 **Category:** Publications **Keywords:** Time-Resolved Fluorescence, TRF immunoassay, Europium chelate, POCT fluorescence — ## Introduction Despite the rise of new detection technologies, Time-Resolved Fluorescence (TRF) using Europium chelates remains the gold standard for sensitive POCT immunoassays. Here’s why. ## What is Time-Resolved Fluorescence (TRF)? … Read more

# Microfluidic PCR Technology: Complete Guide for IVD Manufacturers 2026 **Category:** Publications **Keywords:** microfluidic PCR, digital PCR, IVD manufacturing, POCT molecular diagnostics — ## Executive Summary Microfluidic PCR has revolutionized point-of-care molecular diagnostics. This guide covers everything IVD manufacturers need to know about implementing microfluidic PCR technology in 2026. ## What is Microfluidic PCR? Microfluidic … Read more

# 10 Critical Factors When Choosing a POCT Reagent Supplier **Category:** Application Notes **Keywords:** POCT reagent supplier, IVD OEM partner, TRF reagent manufacturer — ## Introduction Choosing the right POCT (Point-of-Care Testing) reagent supplier can make or break your IVD business. With countless suppliers claiming ISO certification and FDA compliance, how do you identify the … Read more

Robotic Process Automation (RPA) is revolutionizing POCT manufacturing in 2026, enabling manufacturers to achieve higher throughput, improved quality control, and reduced operational costs. This application note explores how RPA integration benefits POCT producers and their distribution partners. 🤖 What is RPA in POCT Manufacturing? RPA uses software bots to automate repetitive, rule-based tasks in POCT … Read more

The global lateral flow assay (LFA) market is experiencing robust growth, valued at USD 17.44 billion in 2025 and projected to reach USD 25.28 billion by 2035, expanding at a CAGR of 3.78% from 2026 to 2035 (Precedence Research). For IVD professionals, distributors, and manufacturers, understanding these market dynamics is critical for strategic planning in … Read more

The clinic of the future is decentralized and highly automated. The convergence of Point of Care Testing (POCT) hardware and Robotic Process Automation (RPA) software is making this a reality. While POCT devices deliver 15-minute diagnostic results at the patient’s side, RPA handles the backend: billing, inventory deduction, patient notifications, and follow-up scheduling. This holistic … Read more

The development of new Point of Care Testing (POCT) assays, particularly those utilizing CRISPR or Time-Resolved Fluorescence (TRF), involves analyzing massive datasets. Robotic Process Automation (RPA) accelerates this R&D cycle. Bots can automate the structuring of clinical trial data, run thousands of simulated thermal cycling scenarios, and compile research findings. By freeing scientists from data … Read more